Hone Health reports that the controversial 2002 WHI study misled menopause care, linking HRT to breast cancer and causing ...

FDA Commissioner Marty Makary announced that Dr. George Tidmarsh, a cancer and pediatric specialist, will direct the agency's ...

Experts worry the warning on vaginal estrogen menopause treatments is doing more harm than good and is not supported by science.

US Food and Drug Administration Commissioner Marty Makary signaled Thursday that he is open to revising strict warning labels ...

Members of an FDA expert panel discussed reassessing boxed warnings for menopausal HT and how to better educate patients and ...

The FDA is reconsidering the black box warning on estrogen. Experts say it’s time for a change—find out what this means for ...

A panel of 12 experts in the menopause field reexamined the findings of the 2002 Women’s Health Initiative study that said ...

A decades-old label has scared women (and their doctors) away from safe and effective menopause treatment. That could finally change today.

US health authorities on Thursday began a reassessment of the risks surrounding Hormone Replacement Therapy (HRT), a ...

US health authorities are set Thursday to reassess Hormone Replacement Therapy (HRT), a treatment used by menopausal women ...

Join Drs Anne Cross and Riley Bove as they discuss menopause in multiple sclerosis, including overlapping symptoms, hormone therapy, and why this transition shouldn't catch anyone off guard.

Bayer AG BAYRY announced that the FDA has approved a label expansion of kidney disease drug Kerendia (finerenone). The ...